Navigation Links
Neurocrine Announces Phase IIb Results Of VMAT2 Inhibitor NBI-98854 For Treatment Of Tardive Dyskinesia
Date:9/9/2013

SAN DIEGO, Sept. 9, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the 50mg dose of NBI-98854, a small molecule VMAT2 inhibitor in development for tardive dyskinesia, did not meet the primary endpoint in the Phase IIb Kinect study while the 100mg dose showed a statistical and clinically significant improvement. The pre-specified primary endpoint was the change-from-baseline in the Abnormal Involuntary Movement Scale (AIMS) at Week 6 in the intent-to-treat (ITT) population.

Although the 50mg dose of NBI-98854 did not reach statistical significance for the primary endpoint at Week 6, the 100mg dose, utilizing the blinded central video AIMS assessment, showed a statistically significant and clinically meaningful reduction in tardive dyskinesia symptoms at Week 2 (the end of the 100mg dose interval). AIMS scores were reduced by 5.5 points in the 100mg per-protocol (PP) group compared to a reduction of 2.7 points in placebo (p=0.008), and the responder rate (>= 50% improvement from baseline) was 48% in the 100mg group compared to 23% in placebo (p=0.034). The 100mg dose was expected to be a maximum tolerated dose based on earlier data; however in this patient population, 100mg was well tolerated. The pre-specified statistical analysis plan included three data sets: safety set (all subjects with at least one dose), ITT set (all randomized subjects with at least one AIMS assessment) and the PP set (all subjects except those with no detectable drug levels at the evaluation time point).

"Although this was not the result we anticipated in the 50mg dose based on the data set from the earlier clinical studies, we were pleased to see a clear dose related response at the end of Week 2, with the 100mg dose, " said Kevin C. Gorman, President and Chief Executive Officer of Neuroc
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
2. Neurocrine Biosciences Reports First Quarter 2012 Results
3. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
4. Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2012 Financial Results
5. Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results
7. Neurocrine Biosciences To Present At Lazard Capitalmarkets 9th Annual Healthcare Conference
8. Neurocrine Biosciences To Present At Deutsche Banks 2012 dbAccess BioFEST
9. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
10. Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results
11. Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... --  Vestagen Technical Textiles, Inc. today announced that ... received two notable innovation awards. The first is the ... with potential to create a positive impact in the ... New York City , VESTEX received the Silver ... category. The awards honor excellence in new product and ...
(Date:4/24/2015)... 24, 2015 Introduction ... indication-specific planning tools for radiosurgery/SBRT   ... aimed at enhancing the workflow for difficult to ... in 2013 - comes full circle with the ... These new Elements enable on-the-fly generation of consistent ...
(Date:4/24/2015)... - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or the "Company"), ... marijuana products and a licensed producer ("LP") to cultivate ... Canada ) ("MMPR"), is pleased to announce ... closed the transaction announced on March 11, 2015 with ... Transfer") a total of 20,156,790 common shares of T-Bird ...
Breaking Medicine Technology:VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 2VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 3Brainlab Introduces New Generation of VMAT* for Brain and Spine at 3rd ESTRO in Barcelona 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 3
... , SANTA CLARA, Calif. , Feb. 1 ... Dental Association (ADA) sponsors National Children,s Dental Health Month to raise ... an early age and scheduling regular dental visits helps children get ... , (Logo:   http://www.newscom.com/cgi-bin/prnh/20091013/LA91350LOGO ) , For kids that wear ...
... , ABBOTT PARK, Ill. and CASTRES, ... ABT ) announced today an exclusive worldwide licensing agreement with Pierre ... identified at the Centre d,Immunologie Pierre Fabre (CIPF) in France ...  cMet protein plays a role in the progression of a range ...
Cached Medicine Technology:February is National Children's Dental Health Month -- 'Remember to Brush and Floss Every Day' is the Message -- Kids With Braces Need to be Extra Vigilant 2February is National Children's Dental Health Month -- 'Remember to Brush and Floss Every Day' is the Message -- Kids With Braces Need to be Extra Vigilant 3Abbott and Pierre Fabre SA Announce Collaboration to Research and Develop Novel Treatments for Cancer 2Abbott and Pierre Fabre SA Announce Collaboration to Research and Develop Novel Treatments for Cancer 3
(Date:4/25/2015)... In observance of World Malaria Day, today ... Pledge, a two-year pledge by the United Nations Foundation’s ... one million bednets by 2016. This ambitious $10 million ... to protect children, refugees, and families displaced by conflict ... been a large surge in refugee families displaced by ...
(Date:4/25/2015)... NY (PRWEB) April 25, 2015 By definition, ... and data for the enterprise relying on their judgement and ... smoothly. But according to an article published in ... many times actually be doing a disservice to their responsibilities ... are dotted and t’s are crossed when it comes to ...
(Date:4/25/2015)... The URO CENTER of NEW YORK is ... by the New York Academy of Medicine to receive the ... field of Urology. , Dr. Ferdinand Valentine, born in 1851, ... He was a man of rare and attractive personality ... Not only did he devote his life to his profession ...
(Date:4/24/2015)... Constellations Recovery celebrates the opening of the ... 35 miles from New York City, Constellations Recovery was ... while recovering from addiction. The Open House, which is ... doctors and treatment centers to see the residence, tour ... offered by Constellations Recovery.,  , The newly opened facility ...
(Date:4/24/2015)... Houston, TX (PRWEB) April 24, 2015 The ... Dan Long, after their great success of the Xtreme Fat ... the industry. The fat loss blueprint that claims to ... caught the attention of HealthyandFitZone.com's Stan Stevenson, prompting an investigative ... shows that the creators spent years researching and experimenting ...
Breaking Medicine News(10 mins):Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 2Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 5Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 3Health News:Fastest Fat Loss Week Ever Review Revealed on Healthy & Fit Zone 2
... the most lethal form of human cancer, has been ... gene, "Seven-In-Absentia," according to researchers at the American Society ... 2008 in San Francisco. , In their studies ... Clinic College of Medicine in Minnesota, scientists found a ...
... common problem this time of year, experts say , , SUNDAY, ... a festive time for many, it can cause depression for ... financial problems. , For some seniors, this despondency can lead ... that the 2004 suicide rate for Americans over the age ...
... to Conduct a Sales Kaizen event to Improve Your Sales Process in ... in Norcross, GA. A teleconference introducing the book will be held on ... ... December 14, 2008 -- Companies everywhere are struggling to find ways of ...
... a breast cancer prevention study using exemestane (Aromasin) finds ... phase II study details reported today, by Jennifer Eng-Wong, ... Cancer Center at the San Antonio Breast Cancer Symposium, ... are at an increased risk of developing breast cancer ...
... Blood Center (NYBC),will honor New York,s finest this Monday, December ... thousands of New York Police Department (NYPD),Academy recruits for donating ... drives have been held by the Police Academy since 1980, ... A special "Perpetual Plaque" will be presented ...
... Dec. 13 Genomic Health, Inc.,(Nasdaq: ... study demonstrating,that the Oncotype DX Recurrence Score(R) result ... both node-negative and node-positive,hormone receptor-positive breast cancer patients ... with tamoxifen. Researchers from the,Royal Marsden ...
Cached Medicine News:Health News:Blocking molecular pathway with whimsical name possible therapeutic target for pancreatic cancer 2Health News:Helping Seniors Beat the Holiday Blues 2Health News:New Guidebook Published for Improving B2B Sales Results in 90 Days or Less Through Kaizen Events 2Health News:New Guidebook Published for Improving B2B Sales Results in 90 Days or Less Through Kaizen Events 3Health News:NYPD Recruits Recognized for Giving Gift of Life 2Health News:Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors 2Health News:Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors 3Health News:Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors 4Health News:Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors 5Health News:Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors 6
... the LDS-2™ instrument places two stainless steel clips ... and the knife blade divides the tissue between ... by squeezing the instrument's handle firmly as far ... clip is determined by the selection of the ...
The ALLPORT and ALLPORT LS Endoscopic Rotating Multiple Clip Appliers have application for use on tubular structures or vessels. The tissue being ligated should be consistent with the size of the cli...
... Clip Applier is a reusable instrument designed ... This instrument is used with LIGACLIP EXTRA ... 316L stainless steel or titanium. The clips ... structures where a nonabsorbable ligating device is ...
The Tissue Approximating Forceps are to aid in the approximating of the tissue edges....
Medicine Products: